Target ligand generation
    33.
    发明授权
    Target ligand generation 有权
    靶配体生成

    公开(公告)号:US07716030B2

    公开(公告)日:2010-05-11

    申请号:US10790507

    申请日:2004-03-01

    IPC分类号: G06G7/58 G01N33/48

    摘要: Methods of identifying potential ligands for macromolecular targets are disclosed herein. The methods comprise providing models of three dimensional structural information for ligands or a ligand:macromolecule complex, mapping spatial relationships between the models, and identifying one or more pairs of matching bonds. Databases and apparatuses are also provided.

    摘要翻译: 本文公开了鉴定大分子靶标潜在配体的方法。 所述方法包括提供配体或配体:大分子复合物的三维结构信息模型,绘制模型之间的空间关系,以及鉴定一对或多对匹配键。 还提供了数据库和设备。

    Inhibitors of p38
    37.
    发明授权
    Inhibitors of p38 有权
    p38的抑制剂

    公开(公告)号:US07151101B2

    公开(公告)日:2006-12-19

    申请号:US10951409

    申请日:2004-09-27

    摘要: The present invention relates to inhibitors of p38, a mammalian protein kinase involved in cell proliferation, cell death and response to extracellular stimuli. The invention relates to compounds having the formula: or pharmaceutically acceptable salts thereof, wherein R1, Q1, Q2, and X are as described in the specification. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment end prevention of various disorders.

    摘要翻译: 本发明涉及p38的抑制剂,其涉及细胞增殖,细胞死亡和对细胞外刺激的反应的哺乳动物蛋白激酶。 本发明涉及具有下式的化合物:或其药学上可接受的盐,其中R 1,Q 1,Q 2,X均为 在说明书中描述。 本发明还涉及生产这些抑制剂的方法。 本发明还提供了包含本发明抑制剂的药物组合物以及在预防各种疾病的治疗终端中利用这些组合物的方法。

    Inhibitors of p38
    39.
    发明授权

    公开(公告)号:US06635644B2

    公开(公告)日:2003-10-21

    申请号:US09809921

    申请日:2001-03-16

    IPC分类号: C07D48704

    CPC分类号: C07D487/04

    摘要: The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.